Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | ACR Open Rheumatology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1871928085085945856 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | ACR Open Rheumatology |
| description | |
| discipline_display | Rheumatology |
| discipline_facet | Rheumatology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:107040 |
| institution | FRELIP |
| journal_source_facet | ACR Open Rheumatology |
| last_indexed | 2026-07-28T03:35:35.991Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Anifrolumab Plus Standard of Care Reduces Long‐Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real‐World External Control Study Rheumatology General Rheumatology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Rheumatology General Rheumatology |
| subject_facet | Rheumatology General Rheumatology |
| title | Anifrolumab Plus Standard of Care Reduces Long‐Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real‐World External Control Study |
| title_alt | Anifrolumab más estándar de atención reduce el daño cardiovascular a largo plazo en adultos con lupus eritematoso sistémico: Hallazgos de un estudio de control externo del mundo real L'anifrolumab plus soins standard réduit les dommages cardiovasculaires à long terme chez les adultes atteints de lupus érythémateux disséminé : résultats d'une étude de contrôle externe en conditions réelles Anifrolumabe Mais Padrão de Cuidado Reduz Danos Cardiovasculares de Longo Prazo em Adultos com Lúpus Eritematoso Sistêmico: Descobertas de um Estudo de Controle Externo do Mundo Real |
| title_auth | Anifrolumab Plus Standard of Care Reduces Long‐Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real‐World External Control Study |
| title_es_txt | Anifrolumab más estándar de atención reduce el daño cardiovascular a largo plazo en adultos con lupus eritematoso sistémico: Hallazgos de un estudio de control externo del mundo real |
| title_fr_txt | L'anifrolumab plus soins standard réduit les dommages cardiovasculaires à long terme chez les adultes atteints de lupus érythémateux disséminé : résultats d'une étude de contrôle externe en conditions réelles |
| title_full | Anifrolumab Plus Standard of Care Reduces Long‐Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real‐World External Control Study |
| title_fullStr | Anifrolumab Plus Standard of Care Reduces Long‐Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real‐World External Control Study |
| title_full_unstemmed | Anifrolumab Plus Standard of Care Reduces Long‐Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real‐World External Control Study |
| title_pt_txt | Anifrolumabe Mais Padrão de Cuidado Reduz Danos Cardiovasculares de Longo Prazo em Adultos com Lúpus Eritematoso Sistêmico: Descobertas de um Estudo de Controle Externo do Mundo Real |
| title_short | Anifrolumab Plus Standard of Care Reduces Long‐Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real‐World External Control Study |
| title_sort | anifrolumab plus standard of care reduces long‐term cardiovascular damage in adults with systemic lupus erythematosus: findings from a real‐world external control study |
| topic | Rheumatology General Rheumatology |
| url | https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr2.90071?af=R |